Latest on Ultrasound Renal Denervation

Published: 22 June 2022

  • Views:

    Views Icon 4003
  • Likes:

    Heart Icon 7
  • episode_image
    Part 3 | Session 1 ACC 2022 Symposium Michael Weber, Felix Mahfoud, Ajay J Kirtane, Michael Bloch
  • episode_image
    Part 3 | Session 2 TCT 2021 Symposium Chandan Devireddy, Ajay J Kirtane, Felix Mahfoud, Naomi Fisher

Overview

Ultrasound Renal Denervation (uRDN) is an innovative therapy option for the treatment of uncontrolled hypertension. uRDN therapy is delivered in a minimally invasive procedure that may lower high blood pressure by treating overactive renal nerves with ultrasound energy.

 

This page provides an overview of uRDN technology and the latest evidence from its associated RADIANCE clinical program.

 

The PARADISETM System is Limited to Investigational Use Only in the United States. Approved for distribution in CE mark countries only.
This educational content is supported by:

What you will learn:

  • How uRDN works and its potential benefits for patients suffering from uncontrolled hypertension
  • The clinical evidence supporting uRDN and its implications for the field of hypertension
  • The process for building a uRDN centre and therapy network

This page is designed for:

  • Interventional cardiologists
  • General cardiologists
  • Hypertension specialists
  • Nephrologists
  • Interventional radiologists

More from this programme

Part 3

Discussion With Experts

Part 5

Patient Perspective & Provider Referral Development

Understand patient preference and referral development

Part 6

RADIANCE II Pivotal Trial for Paradise Ultrasound Renal Denervation System in Patients With Hypertension

Faculty Biographies

Ajay J Kirtane

Ajay J Kirtane

Professor of Clinical Medicine

Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.

 

In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research interests are in clinical trial…

View full profile